ASSOCIATION OF FACTOR V LEIDEN MUTATION WITH PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA IN KERMANSHAH PROVINCE

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International journal of hematology-oncology and stem cell research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria

  2011cited by this paper
• Incidence of Childhood Cancers in Golestan Province of Iran

  2010cited by this paper
• Thymidilate Synthase and Methionine Synthase Polymorphisms in Children with Acute Lymphoblastic Leukemia in Western Iran

  2010cited by this paper
• Cerebral Venous and Sinus Thrombosis and Thrombophilic Mutations in Western Iran: Association With Factor V Leiden

  2010cited by this paper
• Deep venous thrombosis and thrombophilic mutations in western Iran: association with factor V Leiden

  2010cited by this paper
• Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment.

  2009cited by this paper
• Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran

  2009cited by this paper
• Detection of responsible mutations for beta thalassemia in the Kermanshah Province of Iran using PCR-based techniques

  2009cited by this paper
• The prevalence of factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T among G6PD deficient individuals from Western Iran

  2009cited by this paper
• Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment.

  2009cited by this paper
• Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden

  2008cited by this paper
• Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran

  2008cited by this paper
• Thrombosis and acute lymphoblastic leukaemia

  2007cited by this paper
• Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients.

  2006cited by this paper
• Prevalence of Factor V Leiden and other thrombophilic traits among Cretan children with malignancy

  2005cited by this paper
• A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L‐asparaginase

  2003cited by this paper
• Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration.

  2003cited by this paper
• An analysis of prognostic factors and the five-year survival rate in childhood acute lymphoblastic leukemia.

  2002cited by this paper
• Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration.

  2001cited by this paper
• Prophylactic therapy with enoxaparin during l-asparaginase treatment in children with acute lymphoblastic leukemia

  2000cited by this paper
• Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters

  1999cited by this paper
• Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors.

  1999cited by this paper
• Resistance to activated protein C (APCR) in children with acute lymphoblastic leukaemia—the need for a prospective multicentre study

  1995cited by this paper
• Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency.

  1994cited by this paper
• Mutation in blood coagulation factor V associated with resistance to activated protein C

  1994cited by this paper

• Factor V Leiden 1691G/A and prothrombin gene 20210G/A polymorphisms as prothrombotic markers in adult Egyptian acute leukemia patients

  2014cites this paper
• Effect of Factor V Leiden on Thrombosis in Childhood Leukemia

  2013cites this paper
• PROTHROMBIN G20210A MUTATION IS NOT A RISK FACTOR FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA IN WESTERN IRAN

  2013cites this paper